Beam Therapeutics Inc (NASDAQ: BEAM): Can The Stock Still Lose Despite An 12.46% YTD Gain?
Beam Therapeutics Inc (NASDAQ:BEAM)’s traded shares stood at 1.17 million during the last session, with the company’s beta value hitting 1.88. At the close of